CYTRX CORP

Profile

Company Names

CYTRX CORP

Addresses

11726 SAN VICENTE BOULEVARD, SUITE 650, LOS ANGELES, CA 90049

Phone Numbers

310-826-5648

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$9,531,500.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-07-13 
$8,240,000.00 
$18,240,000.00 
$10,000,000.00 
Equity 
1
2016-02-05 
$1,291,500.00 
$1,291,500.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOEL 
 
CALDWELL 
DIRECTOR
CYTRX CORP
JOHN 
 
CALOZ 
EXECUTIVE OFFICER
CYTRX CORP
ANITA 
 
CHAWLA 
DIRECTOR
CYTRX CORP
CARY 
 
CLAIBORNE 
DIRECTOR
ADIAL PHARMACEUTICALS, INC.   |  CYTRX CORP   |  NEUROSENSE THERAPEUTICS LTD.
CHERYL 
 
COHEN 
DIRECTOR
CYTRX CORP   |  NOVUS THERAPEUTICS, INC.   |  IMMUNITYBIO, INC.
D 
 
HAEN 
EXECUTIVE OFFICER
CYTRX CORP
LOUIS 
 
IGNARRO 
DIRECTOR
CYTRX CORP
LOUIS 
J 
IGNARRO 
DIRECTOR
CYTRX CORP
STEVEN 
 
KREIGSMAN 
EXECUTIVE OFFICER, DIRECTOR
CYTRX CORP
STEVEN 
A 
KRIEGSMAN 
EXECUTIVE OFFICER, DIRECTOR
CYTRX CORP
BENJAMIN 
 
LEVIN 
EXECUTIVE OFFICER
CAMPUS BOOK RENTALS, INC.   |  MATCHBIN INC   |  ETOUCHES, INC.   |  RADIATE MEDIA HOLDING CO   |  CYTRX CORP   |  SIMPRO HOLDINGS, INC.   |  CLOUDCHECKR INC.   |  ETOUCHES TOPCO, INC.   |  AVISO PARTNERS, INC.   |  TRIPLESEAT SOFTWARE HOLDINGS, INC.   |  MOVISTA, INC.   |  MYTONOMY, INC.   |  STACK CONSTRUCTION TECHNOLOGIES, INC.   |  LEVEL STRUCTURED CAPITAL III, L.P.
JOSEPH 
 
RUBINFELD 
DIRECTOR
CYTRX CORP
ERIC 
 
SELTER 
DIRECTOR
CYTRX CORP
JENNIFER 
 
SIMPSON 
DIRECTOR
DELCATH SYSTEMS, INC.   |  SLINGSHOT COFFEE COMPANY, L.L.C.   |  CYTRX CORP
STEPHEN 
 
SNOWDY 
EXECUTIVE OFFICER
CALOSYN PHARMA, INC.   |  KEREOS, INC   |  ABBY MED, LLC   |  CYTRX CORP   |  MULTIVALENT BIOTHERAPIES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-07-28
D/A
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-07-13 
2021-07-29
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-07-13 
2016-02-10
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
 
2016-02-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375